Tanvir Tabish

Title: Innovations by Tanvir Tabish in Pharmaceutical Compositions

Introduction

Tanvir Tabish is an accomplished inventor based in Kent, GB. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of adeno-associated virus (AAV) compositions. With a total of two patents to his name, his work is paving the way for advancements in medical treatments.

Latest Patents

Tanvir's latest patents focus on adeno-associated virus formulations. These patents detail both liquid and lyophilized pharmaceutical compositions that include specific concentrations of L-histidine, sodium chloride, polysorbate 80, and sucrose or trehalose. The formulations are designed to enhance the stability and efficacy of AAV, which is crucial for treating various medical conditions. Additionally, the patents outline methods for preparing these compositions, treating bleeding disorders, and storing AAV formulations effectively.

Career Highlights

Tanvir Tabish is currently associated with Takeda Pharmaceutical Company Limited, where he continues to innovate in the pharmaceutical sector. His expertise in formulating AAV compositions has positioned him as a key player in the development of new therapeutic solutions.

Collaborations

Tanvir has collaborated with notable colleagues, including Christian Fiedler and Eva Fritscher. These partnerships have contributed to the successful development of his innovative pharmaceutical compositions.

Conclusion

Tanvir Tabish's work in the field of pharmaceutical formulations, particularly with adeno-associated virus compositions, showcases his dedication to advancing medical science. His contributions are vital for the future of treatment options in various medical conditions.